HILLERØD — Today, FOSS announced its annual result for 2021 and unveiled a record revenue for the company, a strong profit and increased investment in innovation. The digital investments of recent years have strengthened the business in a year of global crises and have created the foundation for more growth. In 2021, FOSS had a […]
Provides Stockholders Additional Time to Consider $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced that it convened and then adjourned, without conducting any other business, the Company’s Special Meeting of Stockholders (the “Special Meeting”) to provide stockholders additional time to vote on […]
Introducing Grenova 3.0! Our growth at Grenova has never been the result of a single individual, but rather the combined efforts of a dedicated team, long-lasting partnerships, and ongoing collaboration in pursuit of a common goal – to make labs sustainable, efficient, and resilient to supply chain disruptions. Today, we’re honored to announce that Grenova […]
Fluidigm Board of Directors Unanimously Recommends Stockholders Vote “FOR” ALL Proposals TODAY SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) have recommended that Fluidigm stockholders vote “FOR” ALL proposals related to the previously announced strategic capital […]
CALGARY, AB – Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) (“Nanalysis” or the “Company”) announces that the Company has received repayable funding of $4,985,000 to expand manufacturing operations and global markets for nuclear magnetic resonance products from the government of Canada. “We are very thankful for the support from the Canadian government,” said Sean Krakiwsky, founder and Chief Executive […]
New funding to accelerate the scaling of operations and market introduction of its revolutionary “morpholomics” platform. MENLO PARK, Calif. — Deepcell, a life science company pioneering AI-powered single cell classification and isolation for basic and translational research, today announced that it has closed its $73 million Series B round of financing. The new funding will allow […]
Financing demonstrates the value of Laminar Wash technology in accelerating and standardizing therapeutic research and development WOBURN, Mass. — Curiox Biosystems, Inc., the global leader in biological sample preparation automation, announced today the completion of a $15 million (17.1 billion won) Series C financing round. Luha Private Equity led the deal, joined by other existing investors KB Investment Co., […]
San Diego, Calif. – Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ: GTH), Tech Coast Angels, Ladder Ventures, and Hiaqua Investments were joined by existing investors Agilent Technologies (NYSE: A), Co-win Ventures, Vectr Ventures and Berkeley […]
RNA is increasingly the focus of medicine, new therapeutics, and vaccines Eclipsebio leads the field of RNA genomics with a suite of data-driven technologies revealing RNA structure, modifications, interactions, and translation Eclipsebio plans to leverage this capital raise to accelerate the development of pipeline technologies and products SAN DIEGO — Eclipse Bioinnovations, Inc. (Eclipsebio), the leading […]
The Fully Enzymatic Synthesis™ (or FES™) technology by Molecular Assemblies is designed to overcome the length, purity, and accuracy limitations of the chemical DNA synthesis method The company is launching a key customer program to accelerate innovation in established industries and unlock new applications for synthetic DNA SAN DIEGO — Molecular Assemblies, Inc., today announced that it […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
